109 related articles for article (PubMed ID: 4082602)
1. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
Wien Klin Wochenschr; 1985 Nov; 97(22):850-5. PubMed ID: 4082602
[TBL] [Abstract][Full Text] [Related]
2. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
3. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
[TBL] [Abstract][Full Text] [Related]
6. [In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
Strahlenther Onkol; 1987 Mar; 163(3):195-200. PubMed ID: 3563881
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
Sasaki K; Murakami T; Ogino T; Takahashi M
Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
[TBL] [Abstract][Full Text] [Related]
8. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
Radner H; Kärcher H
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Webster L; Hodgkiss RJ; Wilson GD
Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric bromodeoxyuridine (BrdU)/DNA analysis using fresh solid tumors and its clinical significance].
Shimabukuro T; Naito K
Nihon Rinsho; 1992 Oct; 50(10):2391-4. PubMed ID: 1447808
[TBL] [Abstract][Full Text] [Related]
12. Hydrochloric acid denaturation of colorectal tumour tissue infiltrated with bromodeoxyuridine.
Williamson K; Gilliland R; Weir H; Grimes J; Hamilton P; Anderson N; Crockard A; Rowlands B
Cytometry; 1994 Feb; 15(2):162-8. PubMed ID: 8168403
[TBL] [Abstract][Full Text] [Related]
13. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
Morstyn G; Hsu SM; Kinsella T; Gratzner H; Russo A; Mitchell JB
J Clin Invest; 1983 Nov; 72(5):1844-50. PubMed ID: 6355188
[TBL] [Abstract][Full Text] [Related]
14. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
Cheitlin RA; Bodell WJ
Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the phase of synthesis by means of bromodeoxyuridine. Its clinical application in oncology of the head and neck].
Garin L; Barona R; O'Connor E; Armengot M; Basterra J
An Otorrinolaringol Ibero Am; 1991; 18(6):563-74. PubMed ID: 1776663
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
Anal Cell Pathol; 1996 Mar; 10(2):101-13. PubMed ID: 8721953
[TBL] [Abstract][Full Text] [Related]
17. The use of flow cytometry and cell sorting in a human colon carcinoma model.
Noguchi PD; Cunningham RE; Ridge J; Muller J
Cytometry; 1985 May; 6(3):254-9. PubMed ID: 3996140
[TBL] [Abstract][Full Text] [Related]
18. [Study of flow cytometric bromodeoxyuridine (BrdU)/DNA analysis using human solid tumors].
Shimabukuro T; Yamamoto M; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):839-44. PubMed ID: 2496669
[TBL] [Abstract][Full Text] [Related]
19. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
[TBL] [Abstract][Full Text] [Related]
20. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
